{"disease":{"id":"renal-protection","name":"renal protection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05946122","title":"Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":106,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT04027530","title":"Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT02719418","title":"Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses","phase":"","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Maisonneuve-Rosemont Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}